• Home
• News
• About EURAMOS
• About Osteosarcoma
  • About Osteosarcoma
  • Classification of bone tumours
  • Epidemiology of osteosarcomas
  • Causes
  • Presentation
  • Diagnosis
  • Grading and staging
  • Differential diagnosis
  • Prognostic factors
  • Treatment
  • References
  • Useful links
• EURAMOS I Trial
  • Trial Design
  • Objectives
  • Accrual
  • Participating Institutions (members)
  • Trial Management Group (members)
• Art Project
  • Bringing medicine to life
  • Syed
  • Bhavin
  • Omar
  • Charlie
  • Laura
  • Meg
  • Sam
  • Shane
  • Simon
  • Susanna
  • Contacts
• Clinical Trials Information
• Our Collaborators
• FAQs
• Contacts
• Useful Links
• Site Map

News

January 2008

Pan European Clinical Trials under current EU regulations: A training course for data managers, study nurses and junior clinical investigators.

24-25 January 2008, the Selsdon Park Hotel, South Croydon, London.

To read more about the training course click here.

Click here to view the final programme.

If you would like to view the main presentations from the course, click on each of the following:

1. Obtaining Consent: a demonstration of the consent process with discussion. Lesley Fallowfield and Jeremy Whelan
2. Improving Randomisation Rates: Practical steps. Dorothe Carrle
3. SAE Reporting. Trude Butterfass-Bahloul
4. Toxicity Reporting: Guide to CTCAE. Martha Perisoglou
5. Role of the clinical trials pharmacist. Roy Sinclair
6. Art in medicine. Lizzie Burns
7. Quality of life. Gabriele Calaminus
8. The importance of multi-national trials for rare diseases – the EURAMOS model. Matthew Sydes
9. Funding pan-European trials: Role of ESF. Carole Moquin-Pattey
10. European Clinical Research Infrastructures Network (ECRIN). Christine Kubiak
11. GCP: Investigator responsibilities. Nicola Kaganson

February 2007

Bringing Medicine to Life: EURAMOS 1 patients take part in a unique art project by Dr Lizzie Burns

A project inspired by the MRC Clinical Trials Unit in collaboration with Dr Martha Perisoglou in the University College Hospital, London.

Bringing Medicine to Life is a unique project which encourages patients taking part in clinical trials to communicate their feelings and experiences through art. Ten patients with osteosarcoma, treated in the EURAMOS 1 trial, have participated in the art project so far.

Click here to read more about the Art Project.

The paintings and drawings of the EURAMOS 1 patients went on show for the first time at the international Pan European Sarcoma Trials conference in Stuttgart, Germany in November.

Click here to read about the exhibition at the Stuttgart conference.

January 2007

EOI trial results published

Results of the European Osteosarcoma Intergroup (EOI) (Click here to read more about the EOI) osteosarcoma trial (MRC BO06, EORTC 80931) have recently been published. The study assessed whether giving osteosarcoma patients chemotherapy at shorter intervals, by using 'growth factor' (G-CSF) as support, could result in longer survival for more patients compared to the same chemotherapy given at standard intervals.

Click here for more information about the MRC BO06 trial

Click here to view the results publication

Lewis IJ, Nooij M, Whelan J, Sydes MR, Grimer R, Hogendorn PCW, et al. Improvement in Histologic Response, But Not Survival, in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup (MRC BO06, EORTC 80931, ISRCTN86294690). J Natl Cancer Inst 2006; 99:112-129.

November 2006

Pan European Sarcoma Trials : Moving forward in a climate of increasing economic and regulatory pressure

Conference

Stuttgart

30 November - 2 December 2006.

Click here to view news features for this event

Click here to view presentations from the Stuttgart conference.

Click here to read a news report about the conference in the Lancet Oncology

Click here to read the meeting report in Sarcoma

October 2006

Pan European Clinical Trials under current EU Regulations

A training course for data managers, study nurses and junior clinical investigators.

Holmenkollen Park Hotel Rica, Oslo, Norway.

5 - 6 October 2006.

Click here for full details of this event.

April 2006

EURAMOS 1 is now open to recruitment in all four collaborating groups!

EURAMOS 1 – A randomised trial of the European and American Osteosarcoma Study Group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy.

EURAMOS 1 is a collaboration between 4 of the worlds leading osteosarcoma research groups; the groups are the Cooperative Osteosarcoma Study Group (COSS); the Children’s Oncology Group (COG); the European Osteosarcoma Group (EOI) and the Scandinavian Sarcoma Group (SSG).

Recruitment has now commenced in all 4 groups and in a total of nine different countries, including, Germany, USA, UK, The Netherlands, Norway, Sweden, Belgium, Switzerland and Australia!

Please see the accrual section for detailed information regarding recruitment.

A new website for EURAMOS!

We have just launched this new website for EURAMOS. As you may have noticed, we have tried to improve many aspects of the old website. Some of the improvements we have made can be detailed as:

• A new refreshing look to the site
• New additional pages
• Accessibility information
• A Frequently Asked Questions (FAQs) section
• A Sitemap

There are many more improvements to this site which we hope you'll notice whilst browsing.

We hope you like it.

If you have any comments about this webiste, or notice anything not quite right, then please email the Webmaster with your comments.